Clinical Trial Update: Study of Methotrexate in Lupus Erythematosus [Phase 3]

View source ↗

Summary

Phase 3 study of methotrexate in Systemic Lupus Erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED